BioSyent Inc. (TSXV:RX)

BioSyent Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10.95	12.11	7.98	7.86	18.04	20.29
Short-Term Investments	6.45	3.83	18.2	20.83	10.18	5.29
Cash & Short-Term Investments	17.4	15.94	26.19	28.7	28.21	25.58
Cash Growth	-26.54%	-39.13%	-8.74%	1.72%	10.30%	16.40%
Accounts Receivable	5.07	2.87	3.45	3.18	2.49	1.6
Other Receivables	0.35	0.03	0.03	0.32	0.29	0.22
Receivables	5.48	2.99	3.55	3.66	3.21	1.82
Inventory	5.28	5.33	5.89	4.54	2.2	2.07
Prepaid Expenses	0.48	0.2	0.24	0.25	0.46	0.31
Other Current Assets	-	0.01	-	-	-	-
Total Current Assets	28.64	24.47	35.87	37.14	34.08	29.77
Property, Plant & Equipment	1.11	1.16	1.4	1.61	1.85	2.07
Long-Term Investments	7.5	10.1	2.5	-	-	-
Other Intangible Assets	4.81	4.88	1.02	1.09	0.83	0.96
Long-Term Deferred Tax Assets	0.38	0.4	0.36	0.21	0.1	0.03
Long-Term Deferred Charges	0.2	0.2	0.17	0.17	0.12	0.13
Total Assets	42.76	41.36	41.53	40.49	37.17	33.57
Accounts Payable	4.76	4	5.08	5.06	3.56	3.72
Current Portion of Leases	0.2	0.2	0.18	0.17	0.16	0.15
Current Income Taxes Payable	0.76	0.4	0.11	0.32	0.1	0.25
Current Unearned Revenue	0.12	0.81	0.13	0.16	0.31	0.93
Other Current Liabilities	0.01	-	0.03	-	-	0.08
Total Current Liabilities	5.85	5.41	5.53	5.72	4.14	5.14
Long-Term Leases	0.79	0.84	1.04	1.22	1.4	1.56
Long-Term Deferred Tax Liabilities	0.12	0.11	0.2	0.18	0.08	0.08
Total Liabilities	6.75	6.36	6.77	7.12	5.61	6.78
Common Stock	5.14	5.31	5.12	5.37	5.8	6.39
Additional Paid-In Capital	1.77	2.14	2.29	2.23	1.82	1.49
Retained Earnings	29.27	27.73	27.53	25.91	24.12	19.08
Comprehensive Income & Other	-0.17	-0.17	-0.18	-0.14	-0.19	-0.17
Shareholders' Equity	36.01	35	34.76	33.36	31.55	26.8
Total Liabilities & Equity	42.76	41.36	41.53	40.49	37.17	33.57
Total Debt	0.99	1.04	1.22	1.4	1.56	1.71
Net Cash (Debt)	16.41	14.9	24.97	27.3	26.65	23.87
Net Cash Growth	-27.10%	-40.31%	-8.55%	2.42%	11.67%	18.63%
Net Cash Per Share	1.40	1.26	2.05	2.18	2.07	1.82
Filing Date Shares Outstanding	11.25	11.26	11.61	12.1	12.41	12.74
Total Common Shares Outstanding	11.25	11.28	11.74	12.1	12.56	12.81
Working Capital	22.8	19.07	30.34	31.42	29.94	24.64
Book Value Per Share	3.20	3.10	2.96	2.76	2.51	2.09
Tangible Book Value	31.2	30.13	33.74	32.27	30.72	25.83
Tangible Book Value Per Share	2.77	2.67	2.87	2.67	2.45	2.02
Machinery	0.95	0.95	0.91	0.85	0.81	0.75
Leasehold Improvements	0.68	0.68	0.68	0.68	0.68	0.68

Source: S&P Global Market Intelligence. Standard template. Financial Sources.